Blog

The Department of Health has appointed Tim Irish as a non-executive director of the National Institute for Health and Care ...

[:content [\1 \7 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \space \T \h \e \space \s \u \m \m \a \r \y \space \o \f \space \1 \space \A \u \g \u \s \t \space \2 \0 \1 \4 \space \p \r \i \c \e \space \r \e \d \u \c \t \i \o \n \s \space \f \o \r \space \t \h \e \space \2 \0 \1 \4 \space \S \u \p \p \l \e \m \e \n \t \a \r \y \space \C \y \c \l \e \space \A \  " ..."]]

The July 2015 issue of the New Zealand Pharmaceutical Schedule is out and now in effect. There are no major new or revised ...

[:content [\2 \1 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \S \i \x \  \y \e \a \r \space \o \l \d \space \A \m \e \l \i \a \space \M \c \C \r \o \h \a \n \' \s \space \o \n \e \space \C \h \r \i \s \t \m \a \s \space \w \i \s \h \space \h \a \s \space \b \e \e \n \space \g \r \a \n \t \e \d \space \w \i \t \h \space \a \space \s \u \b \s \i \d \y \space \f \o \r \space \a \space \$ \3 \0 \0 \, \0 \0 \0 " ..."]]

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14 PHARMAC tender. The tender reached ...

[:content [\9 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \I \m \p \r \o \v \e \m \e \n \t \s \space \i \n \space \l \u \n \g \space \c \a \n \c \e \r \space \t \r \e \a \t \m \e \n \t \space \a \r \e \space \s \e \t \space \t \o \space \c \o \n \t \i \n \u \e \space \w \i \t \h \space \a \space \P \H \A \R \M \A \C \space \d \e \c \i \s \i \o \n \space \t \o \space \e \x \t \e \n \d \space \f \u \n \d \i \n \g \space \f \o \r " ..."]]

The report to PBAC on PBS medicines used to treat asthma in children has now been published on the asthma ...

The NICE Annual Review 2013/14 is now available and offers a snapshot of the institute's work over the past 12 months, ...

Theravance Biopharma, Inc. today announced that Health Canada has approved Vibativ (telavancin) for the treatment of adult patients with hospital-acquired bacterial pneumonia (HAP) and ...

Merck Canada Inc. announced today that Keytruda (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. ...

CADTH has received notice of a pending submission from Biogen for Plegridy (peginterferon beta-1a) for use by patients with relapsing-remitting multiple ...

In an unusual move, a Canadian government watchdog plans to hold a hearing to review what it calls “excessive” pricing ...

Over 2000 brands of common medicines could be slashed in price for millions of Australians – some by as much ...